FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102022343> ?p ?o ?g. }

• W2102022343 endingPage "37" @default.
• W2102022343 startingPage "25" @default.
• W2102022343 abstract "The Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme aims to provide in vitro surveillance data for geographically diverse institutions where meropenem is available for use. The in vitro activity of meropenem and eight comparator antimicrobial agents against 2340 significant pathogens obtained in 1999 was assessed and compared in 14 study centres in Brazil, Mexico and the USA. Isolates were further characterized for production of extended-spectrum β-lactamases (ESBLs), AmpC β-lactamases and carbapenemases. Carbapenems demonstrated their broad spectrum and potency, inhibiting ≥95% of all isolates irrespective of the geographical region or centre type. The overall order of activity of the nine agents tested against all pathogens in 1999 was meropenem (96%) > imipenem (95%) > cefepime (92%) > gentamicin (89%) > piperacillin/tazobactam (88%) > ceftazidime = tobramycin (86%) > cefotaxime (84%) > ciprofloxacin (83%). Thus far, the results from the Americas indicate that meropenem has excellent potency and spectrum of activity despite being prescribed for the treatment of seriously ill patients. In contrast, other ESBLs, fluoroquinolones and aminoglycosides have lost activity in many institutions as a result of the selection of strains producing ESBLs or having AmpC and other resistance determinants. Carbapenem resistance was observed rarely and at a prevalence similar to those reported in earlier studies. Carbapenems appear to be a continuing reliable option for the treatment of serious nosocomial infection." @default.
• W2102022343 created "2016-06-24" @default.
• W2102022343 creator A5018102677 @default.
• W2102022343 creator A5044679653 @default.
• W2102022343 date "2000-08-01" @default.
• W2102022343 modified "2023-09-27" @default.
• W2102022343 title "MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections" @default.
• W2102022343 cites W1553275599 @default.
• W2102022343 cites W156665908 @default.
• W2102022343 cites W1581962345 @default.
• W2102022343 cites W1793465640 @default.
• W2102022343 cites W1925363657 @default.
• W2102022343 cites W1937785817 @default.
• W2102022343 cites W1992437875 @default.
• W2102022343 cites W1993400812 @default.
• W2102022343 cites W1996531472 @default.
• W2102022343 cites W2005982435 @default.
• W2102022343 cites W2015608511 @default.
• W2102022343 cites W2031157763 @default.
• W2102022343 cites W2036063866 @default.
• W2102022343 cites W2040443954 @default.
• W2102022343 cites W2076322521 @default.
• W2102022343 cites W2082485437 @default.
• W2102022343 cites W2090888775 @default.
• W2102022343 cites W2096620526 @default.
• W2102022343 cites W2106172785 @default.
• W2102022343 cites W2115886814 @default.
• W2102022343 cites W2132341797 @default.
• W2102022343 cites W2136645212 @default.
• W2102022343 cites W2146926410 @default.
• W2102022343 cites W2157766752 @default.
• W2102022343 cites W2157957255 @default.
• W2102022343 cites W2167325086 @default.
• W2102022343 doi "https://doi.org/10.1093/jac/46.suppl_2.25" @default.
• W2102022343 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11065146" @default.
• W2102022343 hasPublicationYear "2000" @default.
• W2102022343 type Work @default.
• W2102022343 sameAs 2102022343 @default.
• W2102022343 citedByCount "61" @default.
• W2102022343 countsByYear W21020223432012 @default.
• W2102022343 countsByYear W21020223432013 @default.
• W2102022343 countsByYear W21020223432014 @default.
• W2102022343 countsByYear W21020223432015 @default.
• W2102022343 countsByYear W21020223432017 @default.
• W2102022343 crossrefType "journal-article" @default.
• W2102022343 hasAuthorship W2102022343A5018102677 @default.
• W2102022343 hasAuthorship W2102022343A5044679653 @default.
• W2102022343 hasBestOaLocation W21020223431 @default.
• W2102022343 hasConcept C2775832221 @default.
• W2102022343 hasConcept C2776685102 @default.
• W2102022343 hasConcept C2776968632 @default.
• W2102022343 hasConcept C2777050379 @default.
• W2102022343 hasConcept C2777637488 @default.
• W2102022343 hasConcept C2777858937 @default.
• W2102022343 hasConcept C2778193466 @default.
• W2102022343 hasConcept C2778266534 @default.
• W2102022343 hasConcept C2778512257 @default.
• W2102022343 hasConcept C2778719061 @default.
• W2102022343 hasConcept C2778974779 @default.
• W2102022343 hasConcept C2779375183 @default.
• W2102022343 hasConcept C2779631663 @default.
• W2102022343 hasConcept C4937899 @default.
• W2102022343 hasConcept C501593827 @default.
• W2102022343 hasConcept C523546767 @default.
• W2102022343 hasConcept C54355233 @default.
• W2102022343 hasConcept C71924100 @default.
• W2102022343 hasConcept C86803240 @default.
• W2102022343 hasConcept C89423630 @default.
• W2102022343 hasConcept C94665300 @default.
• W2102022343 hasConceptScore W2102022343C2775832221 @default.
• W2102022343 hasConceptScore W2102022343C2776685102 @default.
• W2102022343 hasConceptScore W2102022343C2776968632 @default.
• W2102022343 hasConceptScore W2102022343C2777050379 @default.
• W2102022343 hasConceptScore W2102022343C2777637488 @default.
• W2102022343 hasConceptScore W2102022343C2777858937 @default.
• W2102022343 hasConceptScore W2102022343C2778193466 @default.
• W2102022343 hasConceptScore W2102022343C2778266534 @default.
• W2102022343 hasConceptScore W2102022343C2778512257 @default.
• W2102022343 hasConceptScore W2102022343C2778719061 @default.
• W2102022343 hasConceptScore W2102022343C2778974779 @default.
• W2102022343 hasConceptScore W2102022343C2779375183 @default.
• W2102022343 hasConceptScore W2102022343C2779631663 @default.
• W2102022343 hasConceptScore W2102022343C4937899 @default.
• W2102022343 hasConceptScore W2102022343C501593827 @default.
• W2102022343 hasConceptScore W2102022343C523546767 @default.
• W2102022343 hasConceptScore W2102022343C54355233 @default.
• W2102022343 hasConceptScore W2102022343C71924100 @default.
• W2102022343 hasConceptScore W2102022343C86803240 @default.
• W2102022343 hasConceptScore W2102022343C89423630 @default.
• W2102022343 hasConceptScore W2102022343C94665300 @default.
• W2102022343 hasIssue "90002" @default.
• W2102022343 hasLocation W21020223431 @default.
• W2102022343 hasLocation W21020223432 @default.
• W2102022343 hasOpenAccess W2102022343 @default.
• W2102022343 hasPrimaryLocation W21020223431 @default.
• W2102022343 hasRelatedWork W1981690001 @default.
• W2102022343 hasRelatedWork W2072191264 @default.
• W2102022343 hasRelatedWork W2102022343 @default.

• next